Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
10.1093/rheumatology/kep120
Saved in:
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-27137 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-271372023-10-29T22:37:06Z Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression Mak, A. Cheak, A.A.C. Tan, J.Y.S. Su, H.C. Ho, R.C.M. Lau, C.S. MEDICINE PSYCHOLOGICAL MEDICINE Cyclophosphamide Lupus Meta-analysis Meta-regression Mycophenolate Nephritis 10.1093/rheumatology/kep120 Rheumatology 48 8 944-952 2011-09-27T05:45:09Z 2011-09-27T05:45:09Z 2009 Article Mak, A., Cheak, A.A.C., Tan, J.Y.S., Su, H.C., Ho, R.C.M., Lau, C.S. (2009). Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression. Rheumatology 48 (8) : 944-952. ScholarBank@NUS Repository. https://doi.org/10.1093/rheumatology/kep120 14620324 14620332 http://scholarbank.nus.edu.sg/handle/10635/27137 000268109000017 Scopus |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Cyclophosphamide Lupus Meta-analysis Meta-regression Mycophenolate Nephritis |
spellingShingle |
Cyclophosphamide Lupus Meta-analysis Meta-regression Mycophenolate Nephritis Mak, A. Cheak, A.A.C. Tan, J.Y.S. Su, H.C. Ho, R.C.M. Lau, C.S. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
description |
10.1093/rheumatology/kep120 |
author2 |
MEDICINE |
author_facet |
MEDICINE Mak, A. Cheak, A.A.C. Tan, J.Y.S. Su, H.C. Ho, R.C.M. Lau, C.S. |
format |
Article |
author |
Mak, A. Cheak, A.A.C. Tan, J.Y.S. Su, H.C. Ho, R.C.M. Lau, C.S. |
author_sort |
Mak, A. |
title |
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
title_short |
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
title_full |
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
title_fullStr |
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
title_full_unstemmed |
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression |
title_sort |
mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression |
publishDate |
2011 |
url |
http://scholarbank.nus.edu.sg/handle/10635/27137 |
_version_ |
1781410575851454464 |